Ohman Kwon

Ohman Kwon

Auto-generated profile, based on publicly available information

Ohman Kwon

Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
OKOhman Kwon
Ohman Kwon
KJKwang Bo Jung
Kwang Bo Jung
KLKyeong-Ryoon Lee
Kyeong-Ryoon Lee
YSYe Seul Son
Ye Seul Son
HLHana Lee
Hana Lee
MSMi-Young Son
Mi-Young Son
Directed differentiation of hPSCs and transition from 3D intestinal organoids into functional hIECs.

21 September 2022 in Gut Microbes
Verified
Journal Article
Open access
HLHana Lee
Hana Lee
KJKwang Bo Jung
Kwang Bo Jung
OKOhman Kwon
Ohman Kwon
YSYe Seul Son
Ye Seul Son
ECEunho Choi
Eunho Choi
MSMi-Young Son
Mi-Young Son
Little is known about the modulatory capacity of the microbiota in early intestinal development. We examined various intestinal models that respond to gut microbial metabolites based on human pluripotent stem cell-derived human intestinal organoids (hIOs): physiologically relevant in vitro fetal-like intestine, intestinal stem cell, and intestinal disease models. We found that a newly isolated Limosilactobacillus reuteri strain DS0384 accelerated maturation of the fetal intestine using 3D hIO with immature fetal characteristics. Comparative metabolomic profiling analysis revealed that the secreted metabolite N-carbamyl glutamic acid (NCG) is involved in the beneficial effect of DS0384 cell-free supernatants on the intestinal maturation of hIOs. Experiments in an intestinal stem cell spheroid model and hIO-based intestinal inflamed model revealed that the cell-free supernatant from DS0384 comprising NCG promoted intestinal stem cell proliferation and was important for intestinal protection against cytokine-induced intestinal epithelial injury. The probiotic properties of DS0384 were also evaluated, including acid and bile tolerance and ability to adhere to human intestinal cells. Seven-day oral administration of DS0384 and cell-free supernatant promoted the intestinal development of newborn mice. Moreover, NCG exerted a protective effect on experimental colitis in mice. These results suggest that DS0384 is a useful agent for probiotic applications and therapeutic treatment for disorders of early gut development and for preventing intestinal barrier dysfunction.

26 September 2024 in Biomaterials
Verified
Journal Article
Open access
YSYe Seul Son
Ye Seul Son
YKYong Hwan Kwon
Yong Hwan Kwon
MLMoo-Seung Lee
Moo-Seung Lee
OKOhman Kwon
Ohman Kwon
YJYu-Jin Jeong
Yu-Jin Jeong
MSMi-Young Son
Mi-Young Son
Exploring host cell specificity, pathogenicity, and molecular mechanisms of the vacuolating cytotoxin A (VacA), secreted by Helicobacter pylori (Hp) is crucial for developing novel treatment strategies. VacA affects subcellular events, particularly mitochondria, at a cell-type-specific level. However, the lack of reliable models that mimic VacA-induced subcellular damages and enable novel drug screening linked to the human stomach clinically limits our understanding of the mitochondrial networks in vivo. Here, human antrum gastric organoids (hAGOs) and tissue samples from Hp-infected patients were used to show the toxic effects of VacA-induced mitochondrial damage mainly in mucus-producing gastric pit cells by employing transcriptional, translational, and functional analyses. In VacA-intoxicated or Hp-infected hAGOs, robust mitochondrial fragmentation in gastric pit cells reduced ATP production during respiration, and loss of mucosal barrier integrity was first demonstrated experimentally. Using hAGOs, clinically relevant small molecules were screened for efficacy, and MLN8054, an Aurora kinase A inhibitor, reversed VacA-induced mitochondrial damage and loss of gastric epithelium integrity. MLN8054 was effective in VacA-treated and Hp-infected hAGOs and mice, highlighting hAGOs as a promising drug-screening model. These findings suggest that mitochondrial quality control may serve as a promising therapeutic target for Hp VacA-mediated toxicity and disease progression.

27 January 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
OKOhman Kwon
Ohman Kwon
HLHana Lee
Hana Lee
JJJaeeun Jung
Jaeeun Jung
YSYe Seul Son
Ye Seul Son
SJSojeong Jeon
Sojeong Jeon
MSMi-Young Son
Mi-Young Son
Three-dimensional human intestinal organoids (hIO) are widely used as a platform for biological and biomedical research. However, reproducibility and challenges for large-scale expansion limit their applicability. Here, we establish a human intestinal stem cell (ISC) culture method expanded under feeder-free and fully defined conditions through selective enrichment of ISC populations (ISC 3D-hIO ) within hIO derived from human pluripotent stem cells. The intrinsic self-organisation property of ISC 3D-hIO , combined with air-liquid interface culture in a minimally defined medium, forces ISC 3D-hIO to differentiate into the intestinal epithelium with cellular diversity, villus-like structure, and barrier integrity. Notably, ISC 3D-hIO is an ideal cell source for gene editing to study ISC biology and transplantation for intestinal diseases. We demonstrate the intestinal epithelium differentiated from ISC 3D-hIO as a model system to study severe acute respiratory syndrome coronavirus 2 viral infection. ISC 3D-hIO culture technology provides a biological tool for use in regenerative medicine and disease modelling.

2 December 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
SPSeonghyeon Park
Seonghyeon Park
OKOhman Kwon
Ohman Kwon
HLHana Lee
Hana Lee
YCYounghak Cho
Younghak Cho
JYJemin Yeun
Jemin Yeun
SISung Gap Im
Sung Gap Im
The need for basement membrane extract (BME) with undefined constituents, such as Matrigel, for intestinal stem cell (ISC) culture in traditional systems poses a significant barrier that must be overcome for the development of clinical-grade, scalable, ready-to-use ISCs. Here, we propose a functional polymer-based xenogeneic-free dish for the culture of intestinal stem cells (XF-DISC), ensuring substantially prolonged maintenance of ISCs derived from 3-dimensional human intestinal organoids (ISCs3D-hIO). XF-DISC enables remarkable expandability, exhibiting a 24-fold increase in cell numbers within 30 days, with long-term maintenance of ISCs3D-hIO for more than 30 consecutive passages (>210 days). In addition, XF-DISC is fully compatible with a cell banking system. Notably, human pluripotent stem cell-derived ISCs3D-hIO cultured on XF-DISC are successfully transplanted into intestinal injury and inflammation mouse models, leading to engraftment and regeneration of damaged mouse intestinal epithelium. As a reliable and scalable xenogeneic-free ISC3D-hIO culture method, XF-DISC is highly promising for the development of regenerative ISC therapy for human intestinal diseases.

12 February 2026 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
WYWon Dong Yu
Won Dong Yu
SLSugi Lee
Sugi Lee
HCHyun-Soo Cho
Hyun-Soo Cho
OKOhman Kwon
Ohman Kwon
JLJung Hwa Lim
Jung Hwa Lim
MSMi-Young Son
Mi-Young Son
Drug-induced gastrointestinal (GI) toxicity is common, dose-limiting and difficult to predict using conventional Caco-2-based assays that lack physiological relevance. Here we evaluate a transepithelial electrical resistance (TEER) assay using nontransformed human intestinal epithelial cells (hIECs), derived from human pluripotent stem cells, which superiorly recapitulated epithelial diversity and polarity as well as intestinal barrier function. Across 17 clinically relevant compounds (cell cycle inhibitors, tyrosine kinase inhibitors and nonsteroidal anti-inflammatory drugs), the hIEC TEER assay outperformed ATP cell viability assays, and the Caco-2 TEER assay (AUC of 0.96 for hIEC TEER, 0.72 for Caco-2 TEER and ≤0.69 for cell viability assays) correlated with integrated GI toxicity scores using a ≥50% TEER reduction cutoff (sensitivity 92%, specificity 100% and accuracy 94%). Drug exposure was quantified by calculating the margin of safety (IC 15 : C max ) and a lumen–surrogate margin of safety for oral agents. For mechanistic insight, transcriptomic analysis using representative chemotherapeutics (paclitaxel and docetaxel) showed the downregulation of cytoskeleton-related pathways, including cytoskeleton in muscle cells, cell adhesion molecules and extracellular matrix–receptor interaction, linking microtubule-targeting chemotherapy to intestinal barrier impairment. This platform provides a robust tool that combines predictive accuracy with the evaluation of cytoskeleton-mediated barrier impairment, enabling the early identification of drug-induced GI toxicity.